ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• How Subcutaneous Delivery Can Help Patients Manage Chronic Conditions

  Read more about how to improve your patients’ outcomes, avoid costly delays to launch, and provide a better return on investment.

• 4 Factors Affecting Solubility Of Drugs

  Improper drug solubility can lead to suboptimal drug delivery and absorption, resulting in ineffective drug efficacy and side effects, so solubility must be evaluated in the early stages of drug discovery.

• Annex 1 – The Brave New World Of Regulatory Compliance

  The revision to Annex 1 will become effective in August 2023. Explore the major changes and considerations along with the next steps to achieve Annex 1 Regulatory compliance.

• Is It Ever Too Soon To Start Your Extractables And Leachables Assessment?

  Learn what you need to know about planning for your extractables and leachables testing programs to mitigate delays to your drug development timelines.

• Applying Automation To The Manufacture Of Drug Delivery Devices

  Automated manufacturing is a powerful but often misunderstood tool available to produce drug delivery and other pharmaceutical devices — whether established designs or innovative new ideas.

• Application Of Nano-Emulsion Technology To Address Unmet Medical Needs: A Case Study Of Clopidogrel IV By 505(b)(2) Pathway

  Review a process where the insoluble and unstable free-base form of clopidogrel is converted to a form with acceptable drug loading and is protected from chemical degradation.

• The Importance Of A Human Centered Approach To Product Development

  To meet the needs of patients, life-saving device innovations are needed for the next generation of delivery devices. As drug manufacturers explore the device world, human factors are a key consideration.

• Patient-Centric Formulations In Pediatric Adherence

  Improving pediatric adherence requires age-appropriate formulations, taste-masking, and swallowability strategies. Regulatory, clinical, and technological insights help overcome barriers and support safer, more effective therapies for children across developmental stages.

• High Potent Formulation Development In Oncology

  Examine the vital role formulation development plays in oncology outsourcing and how sponsors can increase their chances of success with the right CDMO partner.

• An Easy-To-Swallow Depression Drug For Elderly Patients

  Examine how an innovative formulation approach helped a developer create a version of their drug that promotes treatment compliance within the geriatric population.